Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin plus dexamethasone for chronic subdural hematoma
ChiCTR1900021659Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Mar 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Chronic subdural haematoma (CSDH) comparing ATO group with ATO+DXM group (2 arms). Primary endpoint: Comprehensive outcome. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
atorvastatindexamethasone
03
Conditions
Chronic subdural haematoma (CSDH)
Beyond the preview
Go deeper on ChiCTR1900021659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021659.